Renal reabsorption of P i : NaPi-IIa
NaPi-IIa, also known as Npt2a (SLC34A1), is an electrogenic Na + -dependent P i cotransporter expressed in the brush border membranes (BBM) of renal proximal tubules (Custer et al. 1994; Murer et al. 2004) . Its pattern of expression along the proximal tubules matches the major sites of renal P i reabsorption, and its role as the main mediator of that process has been clearly demonstrated in an Npt2
−/− mouse model (Beck et al. 1998) . Npt2 −/− mice show a higher urinary excretion of P i and lower Na + -P i cotransport activity in BBM compared to wild-type animals.
NaPi-IIa is regulated by factors known to control the reabsorption of P i in the kidney (for review see Murer et al. 2000) . This regulation is mediated almost exclusively by the control of the number of cotransporters expressed in the BBM. Thus, phosphaturic factors reduce the expression of NaPi-IIa whereas factors that increase renal P i reabsorption increase BBM NaPi-IIa.
Therefore, knowledge of the mechanisms that control apical expression and membrane retrieval of NaPi-IIa is essential to our understanding of how P i homeostasis is achieved.
In the last few years, the combined work of many laboratories has strongly suggested that the regulation, membrane expression and to some extent the fate of endocytosed proteins depends, at least in part, on the network of interactions in which a particular protein is engaged. Therefore, deciphering the pattern of interactions of a given protein may help us understand how it is regulated.
Identification of proteins that interact with cytoplasmic domains of NaPi-IIa
The first attempts to identify proteins interacting with NaPi-IIa were performed by conventional Y2H screenings. A major limitation of this technique is the requirement for both interacting partners to reach the cell nucleus, in order to activate the corresponding reporter gene. Thus, both the bait and the prey constructs should encode soluble peptides. In the case of integral membrane proteins, this requirement restricts the design as baits to J Physiol 567.1 soluble (cytoplasmic) domains of the protein of interest (i.e. NaPi-IIa). Based on hydropathy plots and antibody accessibility both the N-and C-terminal tails of NaPi-IIa face the cytoplasm (Magagnin et al. 1993; Lambert et al. 1999) . Therefore both tails, as well as an internal loop potentially involved in parathyroid hormone (PTH) regulation (see the following three subsections), were chosen as baits for conventional Y2H screenings of a mouse kidney cDNA library. A minimal requisite to ascribe physiological meaning to the interaction is that both partners must be expressed within the same tissue and subcellular compartment in vivo. Therefore, expression within renal proximal tubules of all NaPi-IIa partners described below was confirmed. A summary of these interactions is shown in Fig. 1 .
Proteins that interact with the N-terminal tail of NaPi-IIa.
Y2H screening indicated that the N-terminal cytoplasmic tail of NaPi-IIa interacts with MAP17 as well as with VILIP-3, a visinin-like protein .
MAP17 is a 17 kDa membrane protein associated with various human carcinomas, but also expressed in normal kidneys. Interestingly, MAP17 also interacts with PDZK1 (also known as CLAMP, CAP70 or Diphor1), a PDZ protein found to associate with the C-terminal tail of NaPi-IIa. Yeast trap assays and GST pull-down experiments suggested that MAP17 interacts only with the last (4th) PDZ domain of PDZK1 . RT-PCR of microdissected tubules indicated the presence of MAP17 mRNA in the S1 and S3 segments of both superficial and deep nephrons. At the protein level, renal expression of MAP17 is restricted to the cortex, with similar intensity in the proximal tubules of superficial and juxtamedullar nephrons. The highest intensity is observed in S1 segments and gradually decreases towards the S3 segments .
VILIP-3 is a member of the neuronal calcium sensors family (Spilker et al. 2000) . This protein family is characterized by calcium binding, myristoylation, and calcium-dependent membrane association. However, very little is known about their function. RT-PCR from microdissected nephron segments was also used to analyse the expression of VILIP-3 mRNA in kidney . This study detected VILIP-3 in all segments from both superficial and deep nephrons. By immunofluorescence, VILIP-3 protein is observed in proximal and distal segments as well as in glomeruli. Interestingly, in contrast to distal tubules where VILIP-3 is distributed throughout the cytoplasm, in proximal tubules it is associated with the BBM.
Proteins that interact with the last intracellular loop of
NaPi-IIa. We found several years ago that NaPi-IIb, a second member of the NaPi-II family, is PTH insensitive (Karim-Jimenez et al. 2000) . Based on chimera studies, the signal responsible for hormonal sensitivity was identified. This signal, located on the last intracellular loop, consists of two positively charged residues in NaPi-IIa (KR) that are replaced by uncharged residues in NaPi-IIb (NI). The
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at Universitaetsspital, Bibliothek, CH-8091 ZUERICH on July 28, 2006 jp.physoc.org Downloaded from PTH sensitivity of the cotransporters can be reverted by swapping just these two isoform-specific residues. Y2H screening performed in our laboratory failed to identify interacting candidates that could provide hints about the molecular mechanism underlying the above findings (S. Pribanic, unpublished observations). However, the KR motif has been recently found to interact with PEX19 (Ito et al. 2004 ), a protein involved in the binding and trafficking of peroxisomal proteins (Jones et al. 2004 ). PEX19 mRNA is expressed in kidneys and in opossum kidney (OK) cells (Ito et al. 2004) . In kidney, protein expression has been suggested in cytosolic and BBM fractions. PEX19 binds to wild-type NaPi-IIa but not to a mutant in which the KR motif is replaced by NI residues (Ito et al. 2004) . Transfection of PEX19 in OK cells stimulates NaPi-IIa endocytosis even in the absence of PTH, suggesting a role in the internalization of the cotransporter.
Proteins that interact with the C-terminal tail of NaPi-IIa.
Apical expression of NaPi-IIa is partially prevented upon truncation of the last three C-terminal residues (TRL). After transfection in OK cells, the TRL mutant fails to reach and/or remain at the plasma membrane and accumulates in the cytoplasm, indicating that these residues are required for proper apical expression (Karim-Jimenez et al. 2001) . The TRL sequence resembles a class-I PSD-95, Discs-large, ZO-1 (PDZ) binding domain. PDZ domains represent a family of protein-protein interacting motifs that are involved in many cellular processes (Nourry et al. 2003) . PDZ proteins often contain other interacting domains (SH3, MAGUK, LRR, WW or PH) and can form homo-or heterodimers, such that they have the capacity to scaffold large protein complexes.
A Y2H screening of a mouse kidney library using the C-terminal tail of NaPi-IIa as prey identified a large number of potential partners (Gisler et al. 2001 . Not surprisingly, several of these proteins are PDZ proteins, among them the NHE3 regulatory factors NHERF1 and NHERF2 (also known as EBP50 and E3KARP, respectively) as well as PDZK1 and PDZK2 (the latter also known as IKEPP). Immunostaining of kidney sections showed that NHERF1 and PDZK1 are expressed in the BBM of proximal tubules, where they overlap with NaPi-IIa (Gisler et al. 2001) ; therefore, interaction between these proteins in vivo is 'topologically' possible. NHERF2 and PDZK2 are also expressed in proximal tubules but they are located subapically (Gisler et al. 2001; Wade et al. 2003) ; this suggests that such interactions are not possible at steady state, when NaPi-IIa resides in the BBM, although they could theoretically take place with NaPi-IIa molecules in transit to/from the plasma membrane. Given the capacity of both NHERF1/2 and PDZK1 to form homo-and heterodimers, it is possible to imagine an apical-subapical network of PDZ-based protein interactions.
NHERF1 and NHERF2 contain two PDZ domains (Weinman et al. 1995 ) and a C-terminal region that interacts with the merlin-ezin-radixin-moesin (MERM) family of cytoskeletal proteins (Yun et al. 1998; Murthy et al. 1998) . The capability of ezrin to bind PKA as well widens the range of processes potentially regulated through association with NHERF1. Overlay assays as well as GST pull-downs indicated that NHERF1 interacts through its first PDZ domain with the C-terminal tail of NaPi-IIa in a TRL-dependent manner (Gisler et al. 2001) . However, TRL-independent interactions have also been reported (Lederer et al. 2003) . PDZK1 and PDZK2 encompass four PDZ domains (Kocher et al. 1999; Gisler et al. 2001) . Interaction with NaPi-IIa takes place between their third PDZ domain and the TRL sequence of the cotransporter (Gisler et al. 2001) . PDZK1 also interacts with myosin VIIb (S. Pribanic, unpublished observations) and dual A-kinase anchoring protein 2 (D-AKAP2) , interactions which could be related to cytoskeletal attachment and intracellular signalling, respectively. In addition, PDZK1 forms heterodimers with NHERF1 and probably self-homodimerizes .
In most cases, the above interactions were further confirmed by several assays, independently of yeast, such as overlay assays, GST pull-downs in BBM isolated from mouse kidney cortex as well as in OK cell lysates, co-immunoprecipitation in OK cells using anti-NaPi-IIa and anti-NHERF1 antibodies.
Role of these interactions
Membrane anchoring and/or trafficking. The specific expression of proteins at either the apical or basolateral membrane can be the consequence of two processes: specific sorting and targeting from the trans Golgi network or selective retention at one membrane post targeting. PDZ-mediated membrane anchoring has been reported for a number of proteins such as cystic fibrosis transmembrane conductance regulator (CFTR) (Moyer et al. 2000) or the multidrug resistance-associated protein MRP2 (Harris et al. 2001 ; for review see Hernando et al. 2004) . The role of NHERF1 as a membrane anchor probably depends on its capacity to associate with the actin cytoskeleton through its MERM-binding domain. Based on in vitro and in vivo studies, apical expression of NaPi-IIa depends, at least partially, on the interaction with NHERF1. Thus, expression of NaPi-IIa is impaired in OK cells upon the introduction of a dominant-negative NHERF1 construct that contains only the first PDZ domain (Hernando et al. 2002) NaPi-IIa in BBM and an increased accumulation of the cotransporter in a subapical compartment (Shenolikar et al. 2002) . These animals also show phosphaturia and an impaired up-regulation of NaPi-IIa in BBM in response to a low phosphate diet (Cunningham et al. 2004) .
Apical expression of NaPi-IIa is also impaired in OK cells after transfection of a dominant-negative form of PDZK1 that contains only the third PDZ domain (Hernando et al. 2002) . The expression of the cotransporter is not affected upon ablation of the PDZK1 gene in mice (Kocher et al. 2003) . However, NaPi-IIa abundance in BBM is reduced in PDZK1-deficient animals fed a high P i diet compared to wild-type , suggesting that PDZK1 may be involved in stabilizing NaPi-IIa at the plasma membrane, at least under high P i dietary conditions.
Results obtained from transfection studies using OK cells also indicated that MAP17 is required for apical localization of PDZK1 . However, hepatic overexpression of MAP17 in mice resulted in a reduction of PDZK1 in liver (Silver et al. 2003) . Similar to the PDZK1-deficient mice, MAP17 transgenic mice show a deficiency of the high-density lipoprotein (HDL) receptor SR-BI and therefore increased plasma HDL. However, the precise role of MAP17 in NaPi-IIa expression and/or regulation remains unknown.
Intracellular signalling. NHERF2 and most probably NHERF1 couple PTH receptors (PTH-R) to the PLC-PKC pathway (Mahon et al. 2002) . Thus, NHERF1 and NHERF2 can associate in vitro with PTH-R and phospholipase C beta 1 (PLCβ1). PTH treatment of cells that express NHERF2 and PTH-R activates PLCβ1 and inhibits adenylyl cyclase. Therefore, the presence of NHERF may determine the activation of intracellular signalling upon binding of PTH to PTH-R. Interestingly, we found that both 1-34 PTH (a fragment that activates PKA and PKC) and 3-34 PTH (a fragment that activates only PKC) activate PLC in kidney slices from wild-type but not from NHERF1 −/− mice (P. Capuano, unpublished observations). Moreover, 3-34 PTH down-regulates NaPi-IIa in wild-type but not in NHERF1 −/− animals. Therefore, NHERF1 seems to couple PTH-R to the PLC-PKC pathway. This role of NHERF1 as a molecular switch of intracellular signalling may explain previous observations that in renal proximal tubules apical PTH-R (through association with NHERF1) signals mostly through PLC-PKC whereas basolateral PTH-R (in the absence of NHERF1) activates both PKA and PKC pathways (Traebert et al. 2000) .
Upon PTH treatment, NaPi-IIa is targeted to lysosomes (Lotscher et al. 1996) whereas NHERF1 and PDZK1 remain attached to the BBM (Déliot et al. 2005) . There is a reduction in the amount of NaPi-IIa that co-immunoprecipitates with NHERF1 in OK cells treated with PTH (in the presence of leupeptin) (Déliot et al. 2005) . The above findings suggest that PTH regulates the association between NaPi-IIa and NHERF1. NHERF1 is constitutively phosphorylated and several serine residues have been identified as the target for different kinases (Hall et al. 1999; He et al. 2001; Raghuram et al. 2003) . We found that PTH, as well as independent pharmacological activation of PKA and PKC, leads to an increased phosphorylation of NHERF1 in kidney (Déliot et al. 2005) . One can hypothesize that phosphorylation could trigger the dissociation of NaPi-IIa-NHERF1 complexes, although this remains to be seen experimentally. Similar to NHERF1, PDZK1 is a phosphoprotein in kidney and PTH leads to an increase in its phosphorylation state (N. Déliot, unpublished observations). It will be interesting to study whether this change in phosphorylation represents a mechanism of regulation of NaPi-IIa-PDZK1 interaction.
Interactions at the level of full-length cotransporter: split-ubiquitin Y2H
Recently, a split-ubiquitin Y2H system was developed in order to detect interactions at the level of integral membrane proteins (Stagljar et al. 1998 ). This system is based on the capacity of the severed C-(Cub) and N-terminal (Nub) halves of ubiquitin (Ub) to reassemble and reconstitute a functional protein (Johnsson & Varshavsky, 1994) . This reassembly is prevented by mutation of an isoleucine to glycine near the N-terminus (NubI to NubG). However, as part of bait/prey fusion proteins, Cub and NubG associate and reconstitute a functional Ub if the bait/prey moieties interact with each other (Stagljar et al. 1998 ). The reconstituted Ub is then recognized by ubiquitin-specific proteases which cleave a transcription factor (TF) fused C-terminal to Cub. The released TF can then translocate to the nucleus and activate the reporter gene as in the conventional Y2H.
In the available split-ubiquitin Y2H system, the integral membrane bait protein is C-terminal to the Cub-TF cassette and the prey is fused to NubG. Because many proteins contain interacting motifs at their C-termini, we inverted the orientation of the parental vector in order to liberate the C-terminus of the bait protein (i.e. NaPi-IIa) from the Cub-TF cassette (S. M. Gisler, unpublished observations). Based on immunofluorescence and biochemical experiments, the TF-Cub-NaPi-IIa fusion protein is expressed in the yeast membrane. membrane-inserted and functionally active cotransporter. In all three cases, interaction was prevented by truncation of the TRL PDZ-binding motif of NaPi-IIa. In addition, we found that full-length NaPi-IIa can form homodimers in yeast, independently of its cytoplasmic C-terminus. This finding was corroborated by co-immunoprecipitation from oocytes injected with cRNAs encoding for HA-and myc-tagged NaPi-IIa.
Conclusions and perspectives
Analysis of the pattern of protein interactions with different segments of NaPi-IIa has provided useful information regarding the molecular mechanisms that control its apical expression/retrieval as well as its hormonal regulation. These interactions were identified by classical yeast two-hybrid screening, using discrete domains of the cotransporter as baits. All interacting partners were expressed in renal proximal tubules and interactions were confirmed in several assays such as GST pull-downs, overlay assays or co-immunoprecipitations. In addition, many of these interactions have been reproduced by a new approach that allows the use of full-length, membrane-inserted proteins as baits.
The functional significance of these interactions is still being unveiled. The phenotypes of the PDZK1 and NHERF1-deficient mice with regard to the expression and/or regulation of NaPi-IIa indicate that these two PDZ-containing proteins do not have redundant roles. Moreover, based on the phenotype of the NHERF1-deficient mice, both NHERF isoforms also have specific roles. Therefore, despite their high degree of homology, NHERF1 and NHERF2 do not seem to functionally overlap. An issue that remains to be experimentally addressed is the relative affinities of all these PDZ proteins for NaPi-IIa in vivo, as well as the effect that the binding of a particular protein may have on the association of a second one.
